1/7
08:04 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
1/7
06:33 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
1/7
06:33 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
12/19
08:10 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $27.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $27.00 price target on the stock.
12/19
07:30 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/19
07:30 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/19
05:33 am
vrdn
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
12/19
05:33 am
vrdn
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
12/17
10:23 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/17
10:23 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/16
10:49 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Medium
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
12/5
11:14 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $44.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $44.00 price target on the stock.
12/5
11:14 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $44.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $44.00 price target on the stock.
12/5
10:59 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/5
10:59 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
11/25
08:05 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Medium
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
11/25
06:53 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
11/25
06:53 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
11/13
08:06 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
11/13
05:02 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
11/13
05:02 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
10/28
08:25 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
10/28
08:04 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
10/28
08:04 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN